Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

NCT01689610 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT01689610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01689610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
March 31, 2016
Enrollment
705 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer